Half Yearly Report
Annual Report
21 January 2026
Trading Update
03 November 2025
Move from Access to Apex Segment of Aquis
23 October 2025
Appointment of Aquis Corporate Adviser
Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatmentsStephen O'Hara | 23 February 2023IG UK | Youtube
Sign up for Investor Alerts
